参考文献/References:
[1] 刘俊霞,张 娜.瑞舒伐他汀对急性冠状动脉综合征患者餐后4 h血脂及心肌血运重建的影响研究[J].陕西医学杂志,2018,47(10):127-129.
[2] 陈曼丽,宫 蕊,齐莉莉,等.丹红注射液联合麝香保心丸治疗冠心病心绞痛疗效及对患者NF-κB、GMP-140的影响[J].陕西中医,2020,41(3):321-323.
[3] 杨晓飞,冯 冰.替罗非班对急性冠状动脉综合征行PCI术患者心功能及心血管不良事件影响研究[J].陕西医学杂志,2017,11(6):70-72.
[4] Palta P,Huang ES,Kalyani RR,et al.Hemoglobin A1c and Mortality in older adults with and without diabetes:Results from the national health and nutrition examination surveys(1988-2011)[J].Diabetes Care,2017,40(4):453-460.
[5] 张春艳,韩振华,郑 阳,等.冠心病患者糖化血红蛋白水平在冠状动脉支架术后再狭窄中的临床意义[J].西安交通大学学报:医学版,2018,39(3):344-348.
[6] Ouchi S,Shimada K,Miyazaki T,et al.Low 1,5-anhydroglucitol levels are associated with long-term cardiac mortality in acute coronary syndrome patients with hemoglobin A1c levels less than 7.0%[J].Cardiovascular Diabetology,2017,16(1):151.
[7] Redfors B,He CH,Palmerini T,et al.The SYNTAX score does not predict risk of adverse events in patients with Non-ST elevation acute coronary syndrome who undergo coronary artery bypass graft surgery[J].Journal of Invasive Cardiology,2017,29(2):42.
[8] Moran CA,Southmayd G,Devireddy CM,et al.Clinical and procedural characteristics of persons living with HIV presenting with acute coronary syndrome[J].AIDS,2020,34(1):81-90.
[9] 侯晓沛,田艳蒙,许 亮,等.糖化血红蛋白水平对稳定性冠心病合并2型糖尿病患者冠状动脉病变程度的影响[J].中国循环杂志,2018,33(5):435-440.
[10] 王柏荣,徐 晶,李晓牧.1型糖尿病患者糖化白蛋白/HbA1c比值与血糖波动幅度及长期血糖控制的相关研究[J].中华内分泌代谢杂志,2020,36(12):1027-1031.
[11] 孙秀芹,包柄楠,颜迪恩,等.糖化血红蛋白与冠心病血运重建患者心功能的相关性[J].中华糖尿病杂志,2017,9(1):32-36.
[12] Ouchi S,Shimada K,Miyazaki T,et al.Low 1,5-anhydroglucitol levels are associated with long-term cardiac mortality in acute coronary syndrome patients with hemoglobin A1c levels less than 7.0%[J].Cardiovascular Diabetology,2017,16(1):151.
[13] Zhang S,Dai J,Jia H,et al.Non-culprit plaque characteristics in acute coronary syndrome patients with raised hemoglobin A1c:An intravascular optical coherence tomography study[J].Cardiovascular Diabetology,2018,17(1):90.
[14] 陈晓菲,姜志荣,孙 品,等.三维斑点追踪技术联合SYNTAX评分评价复杂冠状动脉疾病[J].中国医学影像技术,2020,36(4):529-534.
[15] 王雪芹,邵 柳,吴绮楠.糖尿病在冠脉微血管功能障碍中的作用机制[J].重庆医科大学学报,2020,45(12):42-46.
[16] 康攀攀,姚树桐,周 健,等.糖化白蛋白在动脉粥样硬化发生发展中的作用[J].中国动脉硬化杂志,2018,26(11):1165-1169.
[17] 穆利英,吴 昱,孟 帅,等.急性冠状动脉综合征患者糖化血红蛋白与冠状动脉SYNTAX评分的相关性[J].医学研究杂志,2020,49(8),128-132.
[18] 田丽晓,秦历杰,王龙安,等.糖化血红蛋白联合脑钠肽对老年急性心肌梗死住院患者临床预后的评估价值[J].中华老年医学杂志,2020,39(10):1174-1177.
[19] Nomura H,Arashi H,Yamaguchi J,et al.Relation of adiponectin to cardiovascular events and mortality in patients with acute coronary syndrome[J].The American Journal of Cardiology,2020,140(1):7-12.
[20] 王欢欢,贾斯达,刘 越,等.入院糖化血红蛋白水平对行经皮冠状动脉介入治疗的无糖尿病病史患者远期预后的影响[J].中国循环杂志,2020,35(2):142-149.
相似文献/References:
[1]戴雨濛,张薇薇,孙梦雯△.中老年2型糖尿病患者尿白蛋白/肌酐与认知功能障碍相关性研究[J].陕西医学杂志,2020,49(3):325.
DAI Yumeng,ZHANG Weiwei,SUN Mengwen..Correlation between urine albumin-creatinine ratio and cognitive dysfunction in middle-aged and elderly patients with type 2 diabetes mellitus[J].,2020,49(1):325.
[2]郭建强,赵俊宏,张分队,等.2型糖尿病视网膜病变患者血清HbA1c、CysC检测及临床意义*[J].陕西医学杂志,2020,49(5):619.
GUO Jianqiang,ZHAO Junhong,ZHANG Fendui,et al.Changes of serum HbA1c and CysC in patients with type 2 diabetic retinopathy and their clinical significance[J].,2020,49(1):619.
[3]陈伟国,朱萧玲,常 盼,等.2型糖尿病患者冠状动脉狭窄程度危险因素分析*[J].陕西医学杂志,2020,49(6):672.[doi:DOI:10.3969/j.issn.10007377.2020.06.008]
CHEN Weiguo,ZHU Xiaoling,CHANG Pan,et al.Risk factors of coronary stenosis in patients with type 2 diabetes mellitus[J].,2020,49(1):672.[doi:DOI:10.3969/j.issn.10007377.2020.06.008]
[4]李春梦,王海峰,卢 佩,等.糖尿病肾病患者D-二聚体、纤维蛋白原、胱抑素C检测及临床意义*[J].陕西医学杂志,2020,49(11):1503.[doi:DOI:10.3969/j.issn.1000-7377.2020.11.035]
LI Chunmeng,WANG Haifeng,LU Pei,et al.Detection and clinical significance of D-dimer,fibrinogen,cystatin C in patients with diabetic nephropathy[J].,2020,49(1):1503.[doi:DOI:10.3969/j.issn.1000-7377.2020.11.035]
[5]石 敏,邹 健,李乔岳,等.2型糖尿病患者糖化白蛋白和糖化血红蛋白比值与周围神经病变相关性研究*[J].陕西医学杂志,2020,49(12):1557.[doi:DOI:10.3969/j.issn.1000-7377.2020.12.005]
SHI Min,ZOU Jian,LI Qiaoyue,et al.Association between GA/HbA1c ratio and diabetic peripheral neuropathy in patients with type 2 diabetes[J].,2020,49(1):1557.[doi:DOI:10.3969/j.issn.1000-7377.2020.12.005]
[6]袁 曦,刘浪浪,王 新,等.甲状腺功能正常的2型糖尿病患者血清促甲状腺激素水平与糖化血红蛋白达标相关性分析[J].陕西医学杂志,2022,51(3):303.[doi:DOI:10.3969/j.issn.1000-7377.2022.03.009]
YUAN Xi,LIU Langlang,WANG Xin,et al.Correlation between serum TSH and standard-reaching of HbA1c in type 2 diabetic patients with normal thyroid function[J].,2022,51(1):303.[doi:DOI:10.3969/j.issn.1000-7377.2022.03.009]
[7]南武娟,文申英.急性冠脉综合征大鼠外周血巨噬细胞中脂质稳态与动脉粥样硬化指数相关性研究[J].陕西医学杂志,2022,51(4):401.[doi:DOI:10.3969/j.issn.1000-7377.2022.04.004]
NAN Wujuan,WEN Shenying.Correlation between lipid homeostasis in peripheral blood macrophages and atherosclerosis index of rats model with acute coronary syndrome[J].,2022,51(1):401.[doi:DOI:10.3969/j.issn.1000-7377.2022.04.004]
[8]金鑫燚,康鸣竹,赖正够,等.牙周基础治疗对2型糖尿病伴牙周炎患者龈沟液瘦素水平及临床牙周指标的影响[J].陕西医学杂志,2022,51(5):582.[doi:DOI:10.3969/j.issn.1000-7377.2022.05.016]
JIN Xinyi,KANG Mingzhu,LAI Zhenggou,et al.Effect of basic periodontal therapy on leptin level in gingival crevicular fluid and clinical periodontal indexes in patients with type 2 diabetes mellitus and periodontitis[J].,2022,51(1):582.[doi:DOI:10.3969/j.issn.1000-7377.2022.05.016]
[9]王 晶,刘易婷,刘 哲.替米沙坦联合瑞舒伐他汀治疗糖尿病合并冠心病对患者外周胰岛素抵抗、糖化血红蛋白、脂蛋白和心肌缺血的影响[J].陕西医学杂志,2022,51(5):595.[doi:DOI:10.3969/j.issn.1000-7377.2022.05.019]
WANG Jing,LIU Yiting,LIU Zhe.Effects of telmisartan combined with rosuvastatin on peripheral insulin resistance,glycosylated hemoglobin,lipoproteins and myocardial ischemia in diabetic patients with coronary heart disease[J].,2022,51(1):595.[doi:DOI:10.3969/j.issn.1000-7377.2022.05.019]
[10]马晓军.外周血C肽、糖化血红蛋白和血糖水平与2型糖尿病患者并发症发生关系及其预测价值研究[J].陕西医学杂志,2023,52(9):1211.[doi:DOI:10.3969/j.issn.1000-7377.2023.09.022]